454 related articles for article (PubMed ID: 21788293)
1. Prevalence of faecal carriage of Enterobacteriaceae with NDM-1 carbapenemase at military hospitals in Pakistan, and evaluation of two chromogenic media.
Perry JD; Naqvi SH; Mirza IA; Alizai SA; Hussain A; Ghirardi S; Orenga S; Wilkinson K; Woodford N; Zhang J; Livermore DM; Abbasi SA; Raza MW
J Antimicrob Chemother; 2011 Oct; 66(10):2288-94. PubMed ID: 21788293
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and molecular characterization of Enterobacteriaceae producing NDM-1 carbapenemase at a military hospital in Pakistan and evaluation of two chromogenic media.
Day KM; Ali S; Mirza IA; Sidjabat HE; Silvey A; Lanyon CV; Cummings SP; Abbasi SA; Raza MW; Paterson DL; Perry JD
Diagn Microbiol Infect Dis; 2013 Feb; 75(2):187-91. PubMed ID: 23246367
[TBL] [Abstract][Full Text] [Related]
3. New Delhi Metallo-beta lactamase (NDM-1) in Enterobacteriaceae: treatment options with carbapenems compromised.
Deshpande P; Rodrigues C; Shetty A; Kapadia F; Hedge A; Soman R
J Assoc Physicians India; 2010 Mar; 58():147-9. PubMed ID: 20848811
[TBL] [Abstract][Full Text] [Related]
4. Emergence of NDM-1- and IMP-14a-producing Enterobacteriaceae in Thailand.
Rimrang B; Chanawong A; Lulitanond A; Wilailuckana C; Charoensri N; Sribenjalux P; Phumsrikaew W; Wonglakorn L; Kerdsin A; Chetchotisakd P
J Antimicrob Chemother; 2012 Nov; 67(11):2626-30. PubMed ID: 22796889
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of CHROMagar™ KPC for the detection of carbapenemase-producing Enterobacteriaceae in rectal surveillance cultures.
Panagea T; Galani I; Souli M; Adamou P; Antoniadou A; Giamarellou H
Int J Antimicrob Agents; 2011 Feb; 37(2):124-8. PubMed ID: 21177079
[TBL] [Abstract][Full Text] [Related]
6. In vitro evaluation of antibiotic synergy for NDM-1-producing Enterobacteriaceae.
Berçot B; Poirel L; Dortet L; Nordmann P
J Antimicrob Chemother; 2011 Oct; 66(10):2295-7. PubMed ID: 21807739
[TBL] [Abstract][Full Text] [Related]
7. NDM-1, OXA-48 and OXA-181 carbapenemase-producing Enterobacteriaceae in Sultanate of Oman.
Dortet L; Poirel L; Al Yaqoubi F; Nordmann P
Clin Microbiol Infect; 2012 May; 18(5):E144-8. PubMed ID: 22404169
[TBL] [Abstract][Full Text] [Related]
8. What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline.
Livermore DM; Warner M; Mushtaq S; Doumith M; Zhang J; Woodford N
Int J Antimicrob Agents; 2011 May; 37(5):415-9. PubMed ID: 21429716
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and mechanisms of resistance to carbapenems in Enterobacteriaceae isolates from 24 hospitals in Belgium.
Huang TD; Berhin C; Bogaerts P; Glupczynski Y;
J Antimicrob Chemother; 2013 Aug; 68(8):1832-7. PubMed ID: 23557926
[TBL] [Abstract][Full Text] [Related]
10. High rate of faecal carriage of extended-spectrum β-lactamase and OXA-48 carbapenemase-producing Enterobacteriaceae at a university hospital in Morocco.
Girlich D; Bouihat N; Poirel L; Benouda A; Nordmann P
Clin Microbiol Infect; 2014 Apr; 20(4):350-4. PubMed ID: 23927757
[TBL] [Abstract][Full Text] [Related]
11. A simple phenotypic method for the differentiation of metallo-beta-lactamases and class A KPC carbapenemases in Enterobacteriaceae clinical isolates.
Tsakris A; Poulou A; Pournaras S; Voulgari E; Vrioni G; Themeli-Digalaki K; Petropoulou D; Sofianou D
J Antimicrob Chemother; 2010 Aug; 65(8):1664-71. PubMed ID: 20542902
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002.
Moland ES; Hanson ND; Black JA; Hossain A; Song W; Thomson KS
J Clin Microbiol; 2006 Sep; 44(9):3318-24. PubMed ID: 16954267
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of NDM-1 carbapenemase in patients with diarrhoea in Pakistan and evaluation of two chromogenic culture media.
Day KM; Salman M; Kazi B; Sidjabat HE; Silvey A; Lanyon CV; Cummings SP; Ali MN; Raza MW; Paterson DL; Perry JD
J Appl Microbiol; 2013 Jun; 114(6):1810-6. PubMed ID: 23421744
[TBL] [Abstract][Full Text] [Related]
14. Investigation of VIM, IMP, NDM-1, KPC AND OXA-48 enzymes in Enterobacteriaceae strains.
Demir Y; Zer Y; Karaoglan I
Pak J Pharm Sci; 2015 May; 28(3 Suppl):1127-33. PubMed ID: 26051720
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin.
Falagas ME; Maraki S; Karageorgopoulos DE; Kastoris AC; Mavromanolakis E; Samonis G
Int J Antimicrob Agents; 2010 Mar; 35(3):240-3. PubMed ID: 20034765
[TBL] [Abstract][Full Text] [Related]
16. [Infectious diseases caused by carbapenemase-producing Enterobacteriaceae--a particular challenge for antibacterial therapy].
Stock I
Med Monatsschr Pharm; 2014 May; 37(5):162-72; quiz 173-4. PubMed ID: 24908928
[TBL] [Abstract][Full Text] [Related]
17. Identification and screening of carbapenemase-producing Enterobacteriaceae.
Nordmann P; Gniadkowski M; Giske CG; Poirel L; Woodford N; Miriagou V;
Clin Microbiol Infect; 2012 May; 18(5):432-8. PubMed ID: 22507110
[TBL] [Abstract][Full Text] [Related]
18. Modified Hodge test using Mueller-Hinton agar supplemented with cloxacillin improves screening for carbapenemase-producing clinical isolates of Enterobacteriaceae.
Takayama Y; Adachi Y; Nihonyanagi S; Okamoto R
J Med Microbiol; 2015 Jul; 64(7):774-777. PubMed ID: 25934552
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Carba NP Test in Oregon, 2013.
Morey KE; Vega R; Cassidy PM; Buser GL; Rayar JK; Myers JA; Weissman SJ; Beldavs ZG; Pfeiffer CD
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795386
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of a new commercial media, the CHROMAgar™ mSuperCARBA™, for the detection of carbapenemase-producing Enterobacteriaceae.
Amar M; Shalom O; Adler A
Diagn Microbiol Infect Dis; 2017 May; 88(1):20-22. PubMed ID: 28254249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
